UniTao will take over manufacturing site scheduled for closure, saving over 200 jobs

Chinese company UniTao has agreed to buy a Boehringer Ingelheim manufacturing site in Petersburg, US, which was scheduled to be closed by the end of the year with the loss of 240 jobs.

UniTao will use the active pharmaceutical ingredient (API) manufacturing facility site to make APIs for global distribution, and intends to employ up to 376 people. The company has indicated that the availability of a skilled workforce was a favourable factor in its decision to buy the site.